PT640098E - Gene de coronavirus canino e suas utilizacoesc - Google Patents
Gene de coronavirus canino e suas utilizacoescInfo
- Publication number
- PT640098E PT640098E PT93911346T PT93911346T PT640098E PT 640098 E PT640098 E PT 640098E PT 93911346 T PT93911346 T PT 93911346T PT 93911346 T PT93911346 T PT 93911346T PT 640098 E PT640098 E PT 640098E
- Authority
- PT
- Portugal
- Prior art keywords
- canine coronavirus
- coronavirus gene
- gene
- ccv
- spike gene
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241000711506 Canine coronavirus Species 0.000 title 1
- 208000019698 Cutaneous collagenous vasculopathy Diseases 0.000 abstract 2
- 201000009911 cataract 8 multiple types Diseases 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88019492A | 1992-05-08 | 1992-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT640098E true PT640098E (pt) | 2003-01-31 |
Family
ID=25375695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT93911346T PT640098E (pt) | 1992-05-08 | 1993-05-07 | Gene de coronavirus canino e suas utilizacoesc |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0640098B1 (pt) |
| JP (1) | JP3245169B2 (pt) |
| AT (1) | ATE225805T1 (pt) |
| AU (1) | AU670092B2 (pt) |
| CA (1) | CA2135200C (pt) |
| DE (1) | DE69332375T2 (pt) |
| DK (1) | DK0640098T3 (pt) |
| ES (1) | ES2182827T3 (pt) |
| PT (1) | PT640098E (pt) |
| WO (1) | WO1993023423A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993023421A1 (en) * | 1992-05-08 | 1993-11-25 | Smithkline Beecham Corporation | Universal coronavirus vaccine |
| GB2316681B (en) * | 1993-09-16 | 1998-04-15 | Dimminaco Ag Sa Ltd | Antigenically active proteins/polypeptides and coronavirus vaccines containing the same |
| FR2828405B1 (fr) | 2001-08-09 | 2005-06-24 | Virbac Sa | Vaccin anti-coronavirus |
| GB0217434D0 (en) | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
| US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| GB0315323D0 (en) | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
| CN113583096B (zh) * | 2020-05-01 | 2023-06-30 | 清华大学 | SARS-CoV-2 Spike蛋白受体结合域二聚体及其应用 |
| CN112079906B (zh) * | 2020-07-15 | 2022-11-04 | 张影 | 一种新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒 |
| CN113945714B (zh) * | 2020-07-16 | 2023-01-31 | 南京蓬勃生物科技有限公司 | 新型冠状病毒中和抗体类药物中和能力的检测方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0264979A1 (en) * | 1986-09-05 | 1988-04-27 | Duphar International Research B.V | New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines |
| HUT45559A (en) * | 1987-01-16 | 1988-07-28 | Duphar Int Res | Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis |
| US4904468A (en) * | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
| CA2005291C (en) * | 1988-12-30 | 1999-01-26 | Beverly Dale | Feline infectious peritonitis virus diagnostic tools |
| EP0510773B1 (en) * | 1991-04-25 | 2003-12-17 | Akzo Nobel N.V. | Canine coronavirus subunit vaccine |
| EP0524672A1 (en) * | 1991-06-27 | 1993-01-27 | Duphar International Research B.V | CCV vaccine |
| WO1993023421A1 (en) * | 1992-05-08 | 1993-11-25 | Smithkline Beecham Corporation | Universal coronavirus vaccine |
-
1993
- 1993-05-07 WO PCT/US1993/004692 patent/WO1993023423A1/en active IP Right Grant
- 1993-05-07 JP JP50381394A patent/JP3245169B2/ja not_active Expired - Fee Related
- 1993-05-07 AU AU42515/93A patent/AU670092B2/en not_active Ceased
- 1993-05-07 EP EP93911346A patent/EP0640098B1/en not_active Expired - Lifetime
- 1993-05-07 AT AT93911346T patent/ATE225805T1/de not_active IP Right Cessation
- 1993-05-07 ES ES93911346T patent/ES2182827T3/es not_active Expired - Lifetime
- 1993-05-07 CA CA002135200A patent/CA2135200C/en not_active Expired - Fee Related
- 1993-05-07 DE DE69332375T patent/DE69332375T2/de not_active Expired - Fee Related
- 1993-05-07 DK DK93911346T patent/DK0640098T3/da active
- 1993-05-07 PT PT93911346T patent/PT640098E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE225805T1 (de) | 2002-10-15 |
| CA2135200C (en) | 2001-03-27 |
| AU670092B2 (en) | 1996-07-04 |
| JP3245169B2 (ja) | 2002-01-07 |
| JPH07508421A (ja) | 1995-09-21 |
| WO1993023423A1 (en) | 1993-11-25 |
| DK0640098T3 (da) | 2002-10-28 |
| EP0640098A4 (en) | 1997-01-02 |
| DE69332375T2 (de) | 2003-02-13 |
| EP0640098A1 (en) | 1995-03-01 |
| CA2135200A1 (en) | 1993-11-25 |
| AU4251593A (en) | 1993-12-13 |
| EP0640098B1 (en) | 2002-10-09 |
| DE69332375D1 (de) | 2002-11-14 |
| ES2182827T3 (es) | 2003-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL148079A0 (en) | Human ctla-4 antibodies and compositions containing the same | |
| BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
| PT842934E (pt) | Agonistas de 5-ht1f | |
| BR9909110A (pt) | Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo | |
| ID21526A (id) | 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus | |
| BR9908280A (pt) | Inibidores de enzimas de fosfolipase | |
| BR9812339A (pt) | Processo para branquear os dentes, e, composição de higiene oral para branqueamento do dente | |
| GR3023233T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| DE69414471D1 (de) | Dichtungsanordnung zur Einführung von chirurgischen Instrumenten | |
| MY131388A (en) | Inhibitors of hiv protease useful for the treatment of aids. | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| BR0305258A (pt) | Inibidores de polimerase de ns5b de hcv | |
| FI962247A (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät | |
| ES2190246T3 (es) | Nuevos compuestos de tiazolopirimidina. | |
| ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
| BRPI0407207A (pt) | Método para tratar, prevenir e diagnosticar uma infecção por heliocobacter | |
| IL162917A0 (en) | A lysin from bacteriophage and pharmaceutical compositions containing the same | |
| ES2193919T3 (es) | Inhibidores de la enzima convertidora de endotelina. | |
| ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
| PT640098E (pt) | Gene de coronavirus canino e suas utilizacoesc | |
| ES2180948T3 (es) | Peptido que proviene de una forma soluble de la acetilcolinesterasa, activo como modulador del canal. | |
| EP0387802A3 (en) | 5-substituted-1,4-dihydro-4-oxonaphthyridine-3-carboxylate antibacterial agents | |
| DE69808475D1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
| BR9811643A (pt) | Suplementação quìmica de osso |